Be part of our community by subscribing to our newsletters! Follow the steps below.

1. Subscribe to our Announcement Newsletter. You will receive our news about what do you need to know about our work and the resources available for you. You need to confirm your subscription by email (check your email box and confirm your subscription)

2. Choose your favorite writer. We constantly look for the top minds on the pharmaceutical marketing industry. You can subscribe to their article on their pages and receive every article on your inbox. 

3. Choose the Newsletter that better fits you needs. We recommend the Editor’s pick to receive everything you need to know in one weekly email. 

4. All our newsletters needs to be confirmed by email. After you subscribe on our webpage, you will receive an email asking for your confirmation by clicking a link. Click that link if you want to receive the newsletter. If you don’t receive the email, check your spam box and add our email to your safe sender list. If you address belongs to a company, you may need to forward your confirmation email to your tech department to ask them to add our domain to your company safe sender list. 

You can start here by subscribing to our main Newsletter. Confirm your subscription by clicking CONFIRM on the email you will receive after complete the subscription form.

Don’t forget to check for our other newsletters! Check this page for several options we have for all our users!

NEWSLETTER ANNOUCEMENTS

TPMG FEATURED WRITER NEWSLETTER

On a journey to diverse, inclusive, and more efficient...

A version of this article was previously published on PharmaPhorum. Although orphan drugs represent a sizeable portion of new drug approvals, most rare diseases still lack effective treatment. Even more so than for other conditions, rare disease management contains large care gaps that can only be filled by increased access...

The problem with clinical trials (and how virtual insight-gathering...

A version of this article was previously published in the Journal of mHealth. These days, clinical trials are in the news pretty much daily. Whether successful or not, they can impact not only the perception of a pharmaceutical company but also their stock prices. While still the gold standard of...

The Power of Three: How DDA is Transforming Healthcare...

Data strategy is often seen as just the tech side of things, but it's way more than that. It's about driving a cultural shift towards data-driven decision-making, and that takes alignment and buy-in from all parts of the organization. Without that alignment and investment, the strategy is just a...

Action Plan: Embracing Technology in Medical Affairs

It's true that our world is complex and interconnected, and it can be difficult to make sense of it all. But if we can harness the power of technology and human ingenuity, we can create something truly remarkable - a world where we trust each other and our systems,...

Natalie Yeadon´s Newsletter

Navigating the rapidly changing oncology treatment landscape: how digital...

A version of this article was previously published in the Journal of mHealth. The field of oncology is rapidly growing and evolving. In 2022, global spending on cancer medicines was approximately 196 billion USD, and this number is forecasted to reach $375 billion by 2027. In fact, for the past five...

In-person, hybrid, or digital? State of Pharma meetings and...

A version of this article was previously published on PharmaPhorum. Whether we’re talking offices, medical congresses, or advisory board meetings, the term “hybrid” is often used to signal the ideal state. The place where everyone’s needs are being met. The best of both worlds. In the era of digital transformation, it...

Upcoming webinars (Feb 26–28): Top-5 Trends in Virtual KOL...

About the webinar We’re taking a look at the top trends from 2023 and share our predictions for the new year. Our expert speakers will share their unique industry insights and the “best of the best” virtual collaboration and insight-gathering programs from 2023. They will tie in these trends with tips...

Trends in Virtual Collaboration

A version of this article was previously published in the Journal of mHealth. Two weeks into the new year, you have likely already seen multiple articles on the key trends of 2023 and predictions for 2024. Many of these discuss the expanding role and capabilities of AI and machine learning in...

EDITOR´S PICK

Milliman Medical Index estimates 2024 cost of healthcare for...

SEATTLE--(BUSINESS WIRE)--Milliman, Inc., a premier global consulting and actuarial firm, today announced the release of the 2024 Milliman Medical Index (MMI),...

Klick Health Wraps First Round of $1,000,000 Klick AI...

TORONTO & NEW YORK--(BUSINESS WIRE)-- #AI--Klick Health Co-Founder and Chairman Leerom Segal today confirmed that after receiving over 200 submissions from...

Pfizer Announces New Chief Strategy and Innovation Officer

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that Andrew Baum, M.D., will join the company as Chief Strategy and Innovation...

Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride...

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose...

LOOK WHO IS ON THE MOVE!

Alto Neuroscience Appoints Michael Hanley as Chief Operating Officer

LOS ALTOS, Calif.--(BUSINESS WIRE)--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) today announced the expansion of the Company’s leadership team with the addition...

Inspirna Announces Appointment of Karim Benhadji, M.D., as Chief...

NEW YORK--(BUSINESS WIRE)--Inspirna, Inc., a clinical stage biopharmaceutical company developing first-in-class cancer therapeutics, announced today the appointment of Karim Benhadji, M.D.,...

Be Biopharma Expands Scientific Advisory Board with the Appointment...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Be Biopharma, Inc. (“Be Bio”), a company pioneering the discovery and development of Engineered B Cell Medicines (BCMs), today...

Closed Loop Medicine Appoints Paul Johnson as Non-Executive Director

LONDON--(BUSINESS WIRE)--Closed Loop Medicine Ltd., a leading TechBio company developing combination prescription drug plus software therapy products that deliver personalized dose...

INDUSTRY NEWS

Cancer-Killing New Drug Candidate Utilizing AI to Enhance FDA...

GAINESVILLE, Fla.--(BUSINESS WIRE)--U.S. Precision Medicine, Inc. (USPM), a biopharma company developing novel cancer therapeutics, today announced it will use state-of-the-art artificial...

The Foundation for the National Institutes of Health Announces...

NORTH BETHESDA, Md.--(BUSINESS WIRE)--The FNIH launches the AMP ALS partnership to convene resources and expertise that will accelerate drug discovery and...

CG Life Acquires Berry & Company Public Relations, Further...

CHICAGO & NEW YORK--(BUSINESS WIRE)--CG Life, a science-first, tech-enabled agency for life science, has acquired Berry & Company Public Relations, a...

Qurient Therapeutics Enters CRADA with the National Cancer Institute...

SEONGNAM-SI, South Korea--(BUSINESS WIRE)-- #Qurient--Qurient Co. Ltd. (KRX: 115180), a clinical-stage biotech company based in Korea, entered into a Cooperative Research...